SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927356-98-000493
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
5
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 229851
2 1ST AMD. TO RESEARCH & DEVELOPMENT SIDDCO/NPS EX-10.37 5745
3 CONSENT OF KPMG PEAT MARWICK LLP EX-23.1 938
4 FINANCIAL DATA SCHEDULE EX-27.1 2067
5 RESTATED FINANCIAL DATA SCHEDULE FOR 1996 EX-27.2 2031
  Complete submission text file 0000927356-98-000493.txt   242430
Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 98581813
SIC: 2836 Biological Products, (No Diagnostic Substances)